HOUSTON, Texas, July 30 -- The University of Texas MD Anderson Cancer Center issued the following news release:

* * *

MD Anderson and TOPPAN Holdings announce strategic alliance to co-develop organoid technology for evaluating cancer treatments

* 3D cell culture technology may allow researchers to rapidly test a variety of treatments directly on patient biopsies

* Teams will evaluate technology as clinical tool for personalized cancer therapy

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products